We have observed
14 EP applications
Eliot Michael Ward
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after May 26, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
VACCINIA VIRUS FOR GENE-DIRECTED ENZYME PRODRUG THERAPY
METHODS FOR SUPPRESSING CANCER BY INHIBITION OF TMCC3
PLATFORM AND METHODS FOR ANALYZING EFFECTS OF GENETICS, AGE AND ENVIRONMENT IN STIMULUS-RESPONSE STUDIES USING INDUCED PLURIPOTENT STEM CELLS
METHODS FOR CONDUCTING STIMULUS-RESPONSE STUDIES WITH INDUCED PLURIPOTENT STEM CELLS DERIVED FROM PERINATAL CELLS OR TISSUES
ID4 PROTEIN RESTORES WILD TYPE P53 ACTIVITY
ENZYMATIC ACTIVITY OF LYTIC POLYSACCHARIDE MONOOXYGENASE
DETECTION OF T CELL EXHAUSTION OR LACK OF T CELL COSTIMULATION AND USES THEREOF
HUMAN CELL LINES MUTANT FOR ZIC2
METHODS FOR ESTABLISHING THRESHOLD LIMITS FOR A CHEMICAL OR BIOLOGICAL AGENT IN A TARGET SPECIES
LIQUID FORMULATIONS OF CELECOXIB FOR ORAL ADMINISTRATION
CHELATING BASE PRODUCT FOR USE IN WATER-BASED SYSTEM TREATMENTS AND METHOD OF MAKING BASE PRODUCT